<DOC>
	<DOCNO>NCT00004257</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Radiation therapy use high-energy x-rays damage tumor cell . Combining one drug combine chemotherapy radiation therapy may kill tumor cell . PURPOSE : Phase I trial study effectiveness combine oxaliplatin fluorouracil plus radiation therapy treat patient primary esophageal stomach cancer .</brief_summary>
	<brief_title>Oxaliplatin Fluorouracil Plus Radiation Therapy Treating Patients With Primary Esophageal Stomach Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine maximum tolerate dose dose-limiting toxicity oxaliplatin give combination continuous-infusion fluorouracil radiotherapy patient primary cancer thoracic esophagus gastroesophageal junction . - Determine pharmacokinetics regimen patient population . - Assess somatic p53 mutation cancer esophagus determine relation therapeutic response induce regimen . - Assess , preliminary manner , efficacy regimen patient . OUTLINE : This dose-escalation study oxaliplatin fluorouracil . Patients receive oxaliplatin IV 2 hour day 1 , 15 , 29 fluorouracil IV continuously day 8-42 . Patients also undergo radiotherapy daily , 5 day week , 6 week begin day 8 . Patients without evidence distant disease unresectable local regional invasion undergo esophageal resection day 63-70 ( within 3-4 week completion chemoradiotherapy ) . Patients receive oxaliplatin day 105 , 119 , 133 fluorouracil day 105-147 . Cohorts 3-6 patient receive escalate dos oxaliplatin fluorouracil maximum tolerate dose ( MTD ) determine . The MTD define dose precede 2 3 2 6 patient experience dose-limiting toxicity . Patients follow every 4 week . PROJECTED ACCRUAL : A total 56 patient accrue study within approximately 3 year .</detailed_description>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm primary squamous cell carcinoma adenocarcinoma thoracic esophagus ( 20 cm incisor ) gastroesophageal ( GE ) junction Stage IIII Bronchoscopy biopsy cytology require primary esophageal cancer le 26 cm incisor No disease outside esophagus periesophageal soft tissue GE junction tumor must confine great 2 cm gastric cardia Supraclavicular lymph node station 1 must less 1.5 cm nonpalpable physical examination Nodes 1.5 cm great palpable physical examination must confirm nonmalignant biopsy Subdiaphragmatic lymph node station 1520 must great 1.5 cm No recurrent disease No known brain metastasis PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Life expectancy : Not specify Hematopoietic : WBC least 3,000/mm3 Granulocyte count least 1,500/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin normal AST/ALT great 2.5 time upper limit normal ( ULN ) Alkaline phosphatase great 2.5 time ULN Renal : Creatinine normal OR Creatinine clearance least 60 mL/min Cardiovascular : No symptomatic congestive heart failure No unstable angina pectoris No cardiac arrhythmia Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No grade 2 peripheral neuropathy No history allergy platinum compound No history allergy antiemetic appropriate administration conjunction protocoldirected chemotherapy No concurrent uncontrolled illness No ongoing active infection No malignancy within past 5 year PRIOR CONCURRENT THERAPY : Biologic therapy : No colonystimulating factor therapy first study course Chemotherapy : No prior chemotherapy esophageal cancer At least 4 week since prior chemotherapy Endocrine therapy : Not specify Radiotherapy : No prior radiotherapy esophageal cancer At least 4 week since prior radiotherapy Surgery : No prior resection attempt resection esophageal cancer Other : No concurrent investigational drug No concurrent commercial agent therapy esophageal cancer No concurrent highly active antiretroviral agent ( HAART ) HIVpositive patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>stage I esophageal cancer</keyword>
	<keyword>stage II esophageal cancer</keyword>
	<keyword>stage III esophageal cancer</keyword>
	<keyword>squamous cell carcinoma esophagus</keyword>
	<keyword>adenocarcinoma esophagus</keyword>
</DOC>